$Intellia Therapeutics(NTLA)$ experienced a sharp upward movement, surging over 22.85% in five days, driven by a combination of strong institutional backing and crucial clinical pipeline advancements.Immediate Catalysts for the SurgeThe rapid stock appreciation was fueled by dual positive momentum: an institutional upgrade and significant capital inflow. Citizens JMP upgraded NTLA from "Market Perform" to "Outperform," swiftly boosting market sentiment. Concurrently, ARK Invest added 99,000 shares to its holdings. This institutional confidence coincided with a technical breakout, as trading volume hit 9.4 million shares, far exceeding the daily average, attracting trend-following funds.In Vivo Leadership and Blockbuster PotentialIntellia's core st